Vanguard Diagnostics Private Limited

Vanguard Diagnostics Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U33110DL2015PTC276193 Incorporated 02 February 2015 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹20.87 Cr
▼ 18% YoY
Net profit · FY 2025
₹53.68 Lakh
Net margin 2.6%
EBITDA · FY 2025
₹1.8 Cr
EBITDA margin 8.6%
Authorised capital
₹2.18 Cr
Registered with MCA
Paid-up capital
₹2.17 Cr
Issued & subscribed
Open charges
₹12.05 Cr
Satisfied ₹2.25 Cr
Company age
11 yrs
Est. 2015
Employees · EPFO
30
Provident fund records

About Vanguard Diagnostics Private Limited

Data last updated:

Vanguard Diagnostics Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 February 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2015PTC276193. Its GSTIN is 07AAFCV0190G2ZE (Delhi). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹2.18 Cr and a paid-up capital of ₹2.17 Cr. It is led by directors including Ram Pramod Tiwari and Veena Kohli.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C – 123 Okhla Industrial Area Phase I, New Delhi, Delhi, India – 110017.

As per the financials filed for FY 2025, the company reported a revenue of ₹20.87 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹53.68 Lakh (net margin 2.6%) and EBITDA of ₹1.8 Cr (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 16% over five years.

The company has about 30 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Vanguard Diagnostics. As per MCA filings, the company has open charges of ₹12.05 Cr and satisfied charges of ₹2.25 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company. The company has 1 deal on record (1 secondary share transfer); the latest was in August 2016. Its 7 peer companies in the Healthcare industry (Formulations, Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 2 smaller; the largest is Angia RX Life Science Private Limited with revenue of ₹20.96 Cr.

Vanguard Diagnostics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0007024). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vanguarddiagnostics.com.

Company details

CIN U33110DL2015PTC276193
Registration Number 276193
Incorporation Date 02 February 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-08-0007024

Recognitions & Rankings of Vanguard Diagnostics

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-DL-08-0007024

Contact details

Vanguard Diagnostics Private Limited's registered office is in New Delhi, Delhi. Its website is vanguarddiagnostics.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    C – 123 Okhla Industrial Area Phase I, New Delhi, Delhi, India – 110017
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Vanguard Diagnostics Private Limited, buy the company report.

Comprehensive company report
Vanguard Diagnostics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Vanguard Diagnostics operates one associated brand: Vanguard Diagnostics. Each brand links to its own profile.

BrandDescriptionWebsite
Medical diagnostic reagents and devices are manufactured and marketed.vanguarddiagnostics.com

Business activity

The main business activity of Vanguard Diagnostics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Vanguard Diagnostics Private Limited, buy the company report.

Financials of Vanguard Diagnostics Private Limited

FY 2024 filings available

Vanguard Diagnostics Private Limited reported revenue of ₹20.87 Cr (down 18% YoY) for FY 2025.

Revenue · FY 2025
₹20.87 Cr ▼ 18%
Net profit · FY 2025
₹53.68 Lakh margin 2.6%
EBITDA · FY 2025
₹1.8 Cr margin 8.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 18%
3 years · compounded
▼ 1%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 2%
5 years · compounded
▲ 11%

Revenue fell 18% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 16%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.8 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹53.68 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin8.6%
Net Profit Margin2.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Vanguard Diagnostics Private Limited, buy the company report.

Board of directors of Vanguard Diagnostics Private Limited

Vanguard Diagnostics has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ram Pramod TiwariDirector26 May 201511 Years 5 MonthsCurrent
Veena KohliDirector19 Oct 201511 Years 1 MonthsCurrent
Anil Kumar VirmaniDirector02 Feb 201511 Years 9 MonthsCurrent
Rahul ThakurDirector08 Mar 201511 Years 8 MonthsCurrent

Peer comparison

Vanguard Diagnostics Private Limited is compared with the 7 companies closest to it by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Angia RX Life Science Private Limited₹20.96 Cr (FY 2024)17.0%Roorkee, Uttarakhand, India
Alpha-Pharma Healthcare Private Limited₹20.96 Cr (FY 2025)-36.0%Ambarnath, Maharashtra, India
Jaywin Remedies Private Limited₹20.94 Cr (FY 2025)-35.0%Ahmedabad, Gujarat, India
Bestcare Formulations Private Limited₹20.93 Cr (FY 2025)8.0%Coimbatore, Tamil Nadu, India
Addapt Life Care Private Limited₹20.88 Cr (FY 2025)9.0%Kolkata, West Bengal, India
Vanguard Diagnostics Private Limitedthis company₹20.87 Cr (FY 2025)₹53.68 Lakh2.6%-18.0%30New Delhi, Delhi, India
Macsur Pharmaa (India) Private Limited₹20.84 Cr (FY 2024)5.0%Puduchery, Puducherry, India
Maple Biotech Pvt Ltd₹20.82 Cr (FY 2024)3.0%Pune, Maharashtra, India

To see the full peer comparison of Vanguard Diagnostics Private Limited, buy the company report.

Auditor

Vanguard Diagnostics Private Limited is audited by PANKAJ KUMAR for the financial year 2023.

Auditor firmFinancial yearFirm registration number
PANKAJ KUMARFY 2023096918

Shareholding

The shareholding of Vanguard Diagnostics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Vanguard Diagnostics Private Limited, buy the company report.

Charges & borrowings

Open charges
₹12.05 Cr
Satisfied charges
₹2.25 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹6.50 Cr
Others₹5.55 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
06 Aug 2025101160693Hdfc Bank Limited₹6.5 CrOpen
19 Sep 2023100826439Others₹5 CrOpen
27 Sep 2019100294987Others₹55 LakhOpen
07 Mar 2018100160744Others₹1.25 CrSatisfied
22 Aug 201510596206The Karur Vysya Bank Limited₹1 CrSatisfied

To see the full charge records of Vanguard Diagnostics Private Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Vanguard Diagnostics Private Limited has 1 deal on record (1 secondary share transfer); the latest was in August 2016.

Total deals
1
Secondary share transfer
1

Deals on record (1 of 1)

WhenDealAmountParties
Aug 2016Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Vanguard Diagnostics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Vanguard Diagnostics Private Limited has a workforce of 30 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
30
Active EPFO establishments
1
Employee growth
-3.2%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2730
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18

To see the full employee and EPFO history of Vanguard Diagnostics Private Limited, buy the company report.

GST

Vanguard Diagnostics has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
07AAFCV0190G2ZEDelhiActive01 Jul 2017

To see the full GST registrations and return filing status of Vanguard Diagnostics Private Limited, buy the company report.

Recent activity

Vanguard Diagnostics Private Limited has 6 board changes on record since 2015: 4 appointments and 2 cessations. The latest: Vinod Kumar Midha ceased to be Director on 31 Mar 2016.

Charges
A charge with Hdfc Bank Limited amounted to Rs. 6.50 Cr with Charge ID 101160693 was registered on 06 Aug 2025.
AGM
Vanguard Diagnostics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others of Rs. 5.00 Cr registered on 19 Sep 2023 with Charge ID 100826439 was modified on 12 Sep 2024.
Filing
Vanguard Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge registered on 07 Mar 2018 via Charge ID 100160744 with Others was fully satisfied on 24 Jan 2024.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100826439 was registered on 19 Sep 2023.
Charges
A charge with Others amounted to Rs. 0.55 Cr with Charge ID 100294987 was registered on 27 Sep 2019.
Charges
A charge registered on 22 Aug 2015 via Charge ID 10596206 with The Karur Vysya Bank Limited was fully satisfied on 17 Aug 2019.
Charges
A charge with Others amounted to Rs. 1.25 Cr with Charge ID 100160744 was registered on 07 Mar 2018.
Ceased
Vinod Kumar Midha ceased to be Director.
Appointed
Veena Kohli was appointed as Director.
Charges
A charge with The Karur Vysya Bank Limited amounted to Rs. 1.00 Cr with Charge ID 10596206 was registered on 22 Aug 2015.

5 earlier events are in the company report.

Frequently asked questions

Vanguard Diagnostics is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 February 2015 (11+ years old) and is registered under CIN U33110DL2015PTC276193.

Vanguard Diagnostics has 4 current directors:

The latest financial statements of Vanguard Diagnostics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Vanguard Diagnostics is 07AAFCV0190G2ZE, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Vanguard Diagnostics is U33110DL2015PTC276193. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Vanguard Diagnostics has 3 court cases on record: 3 filed by the company.

Vanguard Diagnostics was incorporated on 02 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.

Vanguard Diagnostics has 1 deal on record (1 secondary share transfer); the latest was in August 2016.

The peers of Vanguard Diagnostics by revenue are Angia RX Life Science Private Limited, Alpha-Pharma Healthcare Private Limited, Jaywin Remedies Private Limited, Bestcare Formulations Private Limited, Addapt Life Care Private Limited and 2 more, all in the Healthcare industry (Formulations, Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Vinod Kumar Midha ceased to be Director on 31 Mar 2016. Veena Kohli was appointed as Director on 19 Oct 2015. Ram Pramod Tiwari was appointed as Director on 26 May 2015. Vanguard Diagnostics has 6 board changes on record in total.

Yes, Vanguard Diagnostics is registered as a small enterprise under Udyam registration (number: UDYAM-DL-08-0007024).